Transforming growth factor-β pathway activity in glioblastoma. - Wikidata - awgldk - TriplyDB

Transforming growth factor-β pathway activity in glioblastoma.

Transforming growth factor-β pathway activity in glioblastoma.

http://www.wikidata.org/entity/Q35742442

about

Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and Lomustine Immunosuppressive mechanisms in glioblastoma.Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome Prioritization schema for immunotherapy clinical trials in glioblastoma.Metformin inhibits proliferation and migration of glioblastoma cells independently of TGF-β2.Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma.TREM-1 expression in craniopharyngioma and Rathke's cleft cyst: its possible implication for controversial pathology.Glioblastoma stem cells exploit the αvβ8 integrin-TGFβ1 signaling axis to drive tumor initiation and progression.EMT- and MET-related processes in nonepithelial tumors: importance for disease progression, prognosis, and therapeutic opportunities.Limited role for transforming growth factor-β pathway activation-mediated escape from VEGF inhibition in murine glioma models.The Unexpected Roles of Aurora A Kinase in Gliobastoma Recurrences.Enhanced circulating transforming growth factor beta 1 is causally associated with an increased risk of hepatocellular carcinoma: a mendelian randomization meta-analysis Umbilical Cord-Derived Mesenchymal Stem Cell-Derived Exosomal MicroRNAs Suppress Myofibroblast Differentiation by Inhibiting the Transforming Growth Factor-β/SMAD2 Pathway During Wound Healing.MicroRNA‑126 inhibits endothelial permeability and apoptosis in apolipoprotein E‑knockout mice fed a high‑fat diet Glioma.Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastoma.TGF-β induces oncofetal fibronectin that, in turn, modulates TGF-β superfamily signaling in endothelial cells.Advances in immunotherapeutic research for glioma therapy.The aryl hydrocarbon receptor links integrin signaling to the TGF-β pathway.Differential Expression and Clinical Significance of Transforming Growth Factor-Beta Isoforms in GBM Tumors.

P2860

Q33755077-05554D47-32C0-45D2-B886-FB0923BE50C9 Q36224048-3A943BFB-AC5D-42BB-85B3-B463A3323CD0 Q37046781-4394C8EA-4F9F-4D64-80C4-9CAFF56915FF Q37078999-D2A49E3A-500F-4FD1-BC3B-327BF0C46175 Q37118676-8EE70C36-3C91-4AE5-A995-B65C23448C0E Q37362574-F74EA191-82C8-463E-97D3-F001EFAAAA96 Q37580426-6BBB6B81-A7E8-45C9-97FE-A908BD5A4473 Q38637150-4BCAF14F-048C-4772-9CB9-1D44E8A6363D Q38677439-C838628A-5EC7-48FE-BCBD-2BF83A1559A4 Q38765212-6DA5CB91-7EC7-409F-9DAB-1DB7509C8865 Q38940139-6E0015A0-2B58-4F21-A971-6FBDDE388F60 Q39195314-EB4DF8FB-0D4E-4634-A0D2-60E63172C761 Q41657665-AF1BA9A8-92DC-4D67-82BD-EA82800B143F Q42546572-55B7D5F1-B2D6-4F83-9275-D1BBF85D4A35 Q46820292-F6EFAC0A-F5D2-466C-B36D-988F22BA7471 Q47296083-15CE6C19-964E-4019-93DC-89475F93CDC6 Q47329655-E1464447-1952-4C20-AD85-86FE2A6F3251 Q47569046-8B5F3151-08B3-4789-BE39-A6F02876E7BA Q50920191-EEA0A347-F183-414A-A3D2-7C939EAACB5C Q52593655-2496093C-9E53-4590-9F70-96935D6200A2

P2860

Transforming growth factor-β pathway activity in glioblastoma.

http://www.wikidata.org/entity/Q35742442

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Transforming growth factor-β pathway activity in glioblastoma.

@ast

Transforming growth factor-β pathway activity in glioblastoma.

@en

type

label

Transforming growth factor-β pathway activity in glioblastoma.

@ast

Transforming growth factor-β pathway activity in glioblastoma.

@en

prefLabel

Transforming growth factor-β pathway activity in glioblastoma.

@ast

Transforming growth factor-β pathway activity in glioblastoma.

@en

P1433

Q35742442-8AF4B0BE-472B-4D3A-8D46-75B85C8A4466

P1476

Q35742442-C54CD970-EE13-4BCA-80BC-F7568F3761BB

P2093

Q35742442-0E80C31D-4105-4C3B-9819-4521D89F8D49

Q35742442-1232A38A-FF1A-4A09-849D-38C45626416F

Q35742442-44999D27-9871-4AED-B8E8-17BEB4D91F1E

Q35742442-872C1223-2878-437C-80B0-19A9389A875D

Q35742442-B5125336-7C29-4AA0-A9B6-FD81E894E4DF

Q35742442-F85449A3-68A9-4D21-8BE9-2AE0DE6255C2

P2860

Q35742442-0441F010-4CF8-4C17-A001-4AD3E9EB1744

Q35742442-04B8F65D-6BCB-4A43-81FB-25D00871FE8F

Q35742442-0C733EDC-982A-40C2-95C8-80C01EEC3A7D

Q35742442-16850DE9-A443-4CEC-BBB6-D2E27021554A

Q35742442-23E367C1-0E1D-4781-B4CA-E4A583C1B868

Q35742442-27F06D57-8FAB-4092-9BDC-767645856E0B

Q35742442-29F60C6C-89F1-4F49-90B9-5C233663FB3B

Q35742442-2C806929-B6E5-40F5-8C38-F84425FE7CD5

Q35742442-3497D9FB-ED04-43A9-9813-5C2A795220F5

Q35742442-3A5D5E7B-13B3-49FA-BFBC-E47BDBC94AA8

P304

Q35742442-52B43615-BDA7-4E3A-89F1-342A3F1B0E4A

P31

Q35742442-D6CE5B1B-6FEF-45C4-9737-D050C370A167

P356

Q35742442-C48D341D-42D5-436F-8075-CDB0E8A489CC

P407

Q35742442-61F83C00-00FC-4B37-81B0-CB72EA98C430

P433

Q35742442-7AA7887E-155F-48FF-98D4-14930B0D376E

P478

Q35742442-B19E2E6B-D8AA-4709-B281-AEA50F7E48D6

P50

Q35742442-2AC93ACC-6B2C-4D6F-AFC2-E0D0AC69FF99

P577

Q35742442-6593C97A-B0A8-40C3-949B-A07A4C430B44

P698

Q35742442-21FD8C08-95EE-4310-8B32-DA6BEFA79378

P932

Q35742442-58DC091E-FAC8-4669-BC66-2AB39C098730

P356

ONCOTARGET.3467

P1433

P1476

Transforming growth factor-β pathway activity in glioblastoma.

@en

P2093

Dorothee Gramatzki

http://www.w3.org/2001/XMLSchema#string

Elisabeth Jane Rushing

http://www.w3.org/2001/XMLSchema#string

Isabel Tritschler

http://www.w3.org/2001/XMLSchema#string

Judith Johanna Schroeder

http://www.w3.org/2001/XMLSchema#string

Karl Frei

http://www.w3.org/2001/XMLSchema#string

Larisa Espinoza

http://www.w3.org/2001/XMLSchema#string

P2860

Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling

USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma

An Id-like molecule, HHM, is a synexpression group-restricted regulator of TGF-beta signalling

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

The 2007 WHO classification of tumours of the central nervous system

A new mathematical model for relative quantification in real-time RT-PCR

Mechanisms of TGF-beta signaling from cell membrane to the nucleus

Smad-dependent and Smad-independent pathways in TGF-beta family signalling

Escaping from the TGFbeta anti-proliferative control

P304

5963-5977

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.3467

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25849941

http://www.w3.org/2001/XMLSchema#string

P932

4467414

http://www.w3.org/2001/XMLSchema#string